-FirstPost.com Uncertainty over the supply of subsidised foodgrain to over 19 lakh families in Assam whose livelihoods are linked to work in the tea gardens is threatening to not only spark dissent among workers but has got the industry leaders worried. To understand the impact, consider the case of Deepak Daori and Monica Daori - both workers at Mokalbari Tea Estate in Dibrugarh district. "We are worried that the our monthly ration might...

-Business Standard This would be in addition to 348 drugs already under price ceiling The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck. This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin...

-The Hindu Nidoda Vaijanath, who follows an integrated farming model, keeps himself updated by reading, consulting scientists Bidar (Karnataka): How many crops can you grow on six acres? For this enterprising farmer from Bidar, the answer is 11. Nidoda Vaijanath of Kamathana village also keeps cows, buffaloes and sheep and also has a mini-poultry farm. His farm has small patches covered with fig, cashew, ginger, watermelon, lime, mosambi, drumstick, brinjal, coriander, mango and curry...

-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...

-The Times of India NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'. The move is aimed at spanning the...